Summary
Elevance Health, Inc. (formerly Anthem, Inc.) announced the closing of a significant notes offering on March 17, 2021. The company successfully raised approximately $3.46 billion in net proceeds by issuing four series of notes with varying maturities and coupon rates: 0.450% Notes due 2023, 1.500% Notes due 2026, 2.550% Notes due 2031, and 3.600% Notes due 2051. These proceeds are intended for general corporate purposes, including working capital, potential acquisitions, debt repayment, and share repurchases. This debt issuance provides Elevance Health with substantial financial flexibility. The company can strategically deploy these funds to enhance its business operations, pursue growth opportunities, and return value to shareholders through stock buybacks. The terms of the notes, including interest payment schedules, redemption options, and provisions for default and change of control, are detailed, offering transparency into the company's financial management and commitment to its debt obligations. Investors should note the maturity dates and the company's ability to redeem these notes under specific conditions.
Key Highlights
- 1Elevance Health closed a notes offering totaling $3.5 billion ($500M 2023 Notes, $750M 2026 Notes, $1B 2031 Notes, $1.25B 2051 Notes).
- 2Net proceeds of approximately $3,461.9 million were raised after deducting underwriting discounts and offering expenses.
- 3Proceeds are earmarked for working capital and general corporate purposes, including acquisitions, debt repayment, and share repurchases.
- 4The notes carry varying interest rates and maturity dates, ranging from 0.450% due 2023 to 3.600% due 2051.
- 5The company has the right to redeem the notes under specific conditions, either partially or in full, with call protection periods and associated premiums.
- 6A change of control event, coupled with a below investment grade rating downgrade by major credit agencies, triggers an offer to purchase the notes at 101% of principal.